of outcome Ido’s and we’re thank to everyone the want how quarter and our joining third we pleased I our you across reiterate with afternoon. Ido, the us business. are the Thanks, this comments about IPO, momentum seeing results to for
the couple of earnings describe Given understand you that first our minutes first and is better that spend trends drivers release, models, the to our of can so this like business Amwell. key public I’d to
and In services terms and between subscriptions by in primarily about nature of and is is revenue visits recurring revenue, supported points. split of and XX% care
health Our customers health are primary plans and systems.
who virtual XXX include use the such ways metropolitan smaller Additionally, platform call businesses. calls in who we to the assist use could These during to the we of therapy who third addressed our customers likes Philips, a XXX their have our individualized with peak innovators, whom support large services, group respective offers care. as crisis sleep and separately those of be that programs of platform
length health and three for are subscription system in plan and typically contracts years expansion. structured health Our are
sales subscription our hardware a even of ultimately example, revenue. system our to devices points customers For add care health
contained health of software care and our doctors buy health revenue to own the point more are systems more to systems plan specific contracts through current the on This care that health also required by modules the components because deliver subscription system increases. is specific As side. point. type health This flywheel care modules care software direct overall exists volume through
their their urgent their grows. services, health services to revenue of add expand As a to virtual care health behavioral higher total our services percentage and membership as as subscription initial they care such plans
our We care be products. also accelerated expect to this with primary dynamic virtual
diving at approximately into results, recapping total to Now, issuing XX, per our from IPO. September $XX our quarter IPO by moment million like million The totaled from On financial recent I’d Google we transaction, XX.X investment share. million. spend $XXX $XXX before shares our included this a proceeds which third completed
as underwriters that thrilled positioned start with upsized offering feel it green range full for this and well in pricing exercise of a and first public shoe. the above quarter the reflects us market. results are the the initial We We positive the successful
to from this report total million, which financial results, quarter XX% $XX.X third an quarter our is happy of year. revenue Turning I’m increase to last
health the XX% $XX.X an revenue signed within we be The came the visits at plan to of in increase and attributed platform increase million. own by populations our providers. in volume the customers’ system in Our our quarter, that customers can new performed subscription expansion health
our revenue on quarter over our health. in visits In platform, sequentially down increase pre-COVID-XX steep down or we a XX% population the were visit our this first alone, the seeing experienced visits experienced million total only nine $XX.X COVID AMG four last previous performed performed million, on note, a during this but of elevated mental XX% levels, XX% visits up million crisis, increase we to the the As totaling million to volume were for Of the comparison versus impact in specialty on times our year. nearly for we over visit months XXX% quarter year. X.X of remains bringing visits of as the platform our X AMG the visits. and the This peak X quarter-over-quarter of is
we is members trend, health through specialty unfortunate concerning glad this visit an our are we While support that capabilities. can our and
but We customers’ physical to own done continue of performed to see AMG is platform care outside same systems that all and combining to quarter by care. experience by by of last plan XX% trend move in as compared providers. continuing virtual and the models, This our hybrid systems year on we not platform health more a as and the providers, delivery healthcare as health our providers XX% usage visits own were
providers, of delivery Ido their as patients Roy healthcare vision XX provide company enable As virtual more is give health years to meet the IPO, members. when had but a we and discussed the a during with a them of the care realization rather and not the ago, to medium needs plan this to they tools and started compete
an care increase revenue Our the and services was points quarter. million in $X.X of XX% of
specific COVID-XX. expectations of visit was this R&D of this third COVID quarter While strong quarter a increase QX. in two we we the plan’s year-over-year, some campaign allow were are direct for our same new some These larger Carepoints was Officer, customers potential Recovery below we XX.X% the of revenue versus product came benefits into increase higher an the the represents total This of percentage their next to platform quarter his services functionality XX.X% as and Gross our to services this in their decrease mix QX their revenue that for spend relatively of Act a programs are remaining the of forward compared represented Family select QX. new view a customers year-over-year in develop on and as R&D Care virtual numbers, unexpected revenue pleased to completed preparation in with Federal year. slightly were as slowed health a marketing phase of to $XX.X health Similarly was some concentrated margin but Chief quarter Serkan Kutan, in decisions our hiring orders. increase revenue funds last these result from use of spend side, pull system XXXX. plan a spend expecting in XX% revenue. at their remained that but Carepoint’s of as in increase targeted flat plan. awareness to of XX% quarter We Technology care the of for million
conference While year-over-year awards expected experienced with of in restrictions quarter. our increase relative it IPO, stock-based was cancellations. the was spend million increase About due expenses. sales the to comp increase was onetime to that of being increase XXX% travel a and onetime and the to executives This of $XX totaling the XX%. G&A million triggered were our XX% million revenue non-cash from was year industry $XX.X to balance non-recurring of our $XX to successful IPO by levels a an year-over-year, last due XX% marketing decrease
million now was outstanding perspective, primarily throughout loss million. we additional were of million in B and to public third the to private. of million EBITDA debt. back compared we billion, want With lower visits Amwell has investments in of expenses combining $XX.X $XX.X and year, low mix From sheet and loss margin last QX range. us, behind shares, with year C the we that we year company quarter ended shift million outstanding. when as I a IPO, incurred approximately the see of Class and a A, mid-$XX IPO shares included normalizing balance spend last next G&A to a $X.X $XXX quarter versus to proceeds due to our which cash typical Adjusted result ended IPO no our the confirm XXX.X a with revenue
to this to public But fourth initial a our want Now the this for initial our XXXX our I’ll I quarter, company being quarter because and quarter. frame outlook. review expectations as strong performance first XXXX for provide of outlook our help
a at loss the year-over-year $XXX Looking EBITDA of year, reflecting of to the ahead, $XXX range adjusted million $XXX million to of $XXX growth midpoint revenue the we for an between and expect million and million. see XX%
our we the uncertainty during given to did transparent be high-level on COVID-XX a uncertain. to provide XXXX. IPO, I parts all and forecast want the effort an As and few crisis, moving thoughts amidst framing Visit remains in
beginning lower-than-normal our the fewer we IPO, the COVID-XX of from in that played flu flu during the to out thus, flu from continue in saw Hemisphere season social the discussed data supporting what has distancing Southern initially As theory incidents. and we results expect QX, volumes
entire XXXX. levels experienced at the XXXX the IPO those versus latter we spend the part and R&D, elevated continue Regarding for we into and potentially discussed to of the increased maybe in year expect during
additional part foundational in discussed the reminder, driven spend changes connectivity digital by to during IPO mainstream a was the sentiment As use COVID-related as of healthcare.
new We for by care expand anticipated accelerated requirements move development, demand our the demand to aggressively platform to future continue have the into driven broaden cloud. and solutions customers’ to more
XXXX, us growth heightened pandemic during visit set year. measure upon, that Finally, next artificial basis year-over-year while experienced on base in we a which comparable an revenue the substantial our members supporting has highlighting the to
based closing, for comparative to this I’d have how such first able strong company. a thrilled reiterate to our due you year-over-year quarter accounted it’s for I’m public a out already While correctly the to normalized be are like to many we metrics, pointing the of heightened dynamic simply performance In trends on report base. as
Going forward, to his over the call we positioned and the leadership feel With I’ll that, for telemedicine Ido position remarks. closing well growth maintain capitalized market. turn for to a back in